Need Assistance?
  • US & Canada:
    +
  • UK: +

lacticin Q

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

lacticin Q is an antibacterial peptide isolated from Lactococcus lactis QU 5. It has activity against gram-positive bacteria.

Category
Functional Peptides
Catalog number
BAT-012546
Synonyms
Met-Ala-Gly-Phe-Leu-Lys-Val-Val-Gln-Leu-Leu-Ala-Lys-Tyr-Gly-Ser-Lys-Ala-Val-Gln-Trp-Ala-Trp-Ala-Asn-Lys-Gly-Lys-Ile-Leu-Asp-Trp-Leu-Asn-Ala-Gly-Gln-Ala-Ile-Asp-Trp-Val-Val-Ser-Lys-Ile-Lys-Gln-Ile-Leu-Gly-Ile-Lys
Sequence
MAGFLKVVQLLAKYGSKAVQWAWANKGKILDWLNAGQAIDWVVSKIKQILGIK
1. Structural analysis and characterization of lacticin Q, a novel bacteriocin belonging to a new family of unmodified bacteriocins of gram-positive bacteria
Koji Fujita, Shiro Ichimasa, Takeshi Zendo, Shoko Koga, Fuminori Yoneyama, Jiro Nakayama, Kenji Sonomoto Appl Environ Microbiol. 2007 May;73(9):2871-7. doi: 10.1128/AEM.02286-06. Epub 2007 Mar 9.
Lactococcus lactis QU 5 isolated from corn produces a novel bacteriocin, termed lacticin Q. By acetone precipitation, cation-exchange chromatography, and reverse-phase high-performance liquid chromatography, lacticin Q was purified from the culture supernatant of this organism, and its molecular mass was determined to be 5,926.50 Da by mass spectrometry. Subsequent analyses of amino acid and DNA sequences revealed that lacticin Q comprised 53 amino acid residues and that its N-terminal methionine residue was formylated. In contrast to most bacteriocins produced by gram-positive bacteria, lacticin Q had no N-terminal extensions such as leader or signal sequences. It showed 66% and 48% identity to AucA, a hypothetical protein from Corynebacterium jeikeium plasmid pA501, and aureocin A53, a bacteriocin from Staphylococcus aureus A53, respectively. The characteristics of lacticin Q were determined and compared to those of nisin A. Similar to nisin A, lacticin Q exhibited antibacterial activity against various gram-positive bacteria. Lacticin Q was very stable against heat treatment and changes in pH; in particular, it was stable at alkaline pH values, while nisin A was inactivated. Moreover, lacticin Q induced ATP efflux from a Listeria sp. strain in a shorter time and at a lower concentration than nisin A, indicating that the former affected indicator cells in a different manner from that of the latter. The results described here clarified the fact that lacticin Q belongs to a new family of class II bacteriocins and that it can be employed as an alternative to or in combination with nisin A.
2. Lacticin Q-mediated selective toxicity depending on physicochemical features of membrane components
Fuminori Yoneyama, Kanako Ohno, Yuichi Imura, Mengqi Li, Takeshi Zendo, Jiro Nakayama, Katsumi Matsuzaki, Kenji Sonomoto Antimicrob Agents Chemother. 2011 May;55(5):2446-50. doi: 10.1128/AAC.00808-10. Epub 2011 Jan 31.
Lacticin Q, a lactococcal pore-forming bacteriocin, shows activity toward Gram-positive bacteria but not Gram-negative bacteria. Lacticin Q did not induce permeability of the outer membrane of Gram-negative bacteria. Experiments using model membranes containing outer membrane components suggested that lacticin Q binds to the outer membrane of Gram-negative bacteria but is unable to penetrate it. The lack of activity of lacticin Q was attributed to physicochemical features of the outer membrane components.
3. Secretory expression of lacticin Q fused with SUMO in Bacillus subtilis
Zhanqiao Yu, Qing Wang, Qingshan Ma, Rijun Zhang Protein Expr Purif. 2013 May;89(1):51-5. doi: 10.1016/j.pep.2013.02.014. Epub 2013 Mar 5.
Lacticin Q is a 53-amino acid Class II bacteriocin produced by Lactococcus lactis QU 5. It shows antibacterial activity comparable to that of nisin A in terms of both spectrum and intensity. Moreover, it remains stable at alkaline pH values, while nisin A was inactivated. It may possibly be employed as an alternative to or in combination with nisin A. The objective of this study was to express lacticin Q extracellularly with Small ubiquitin-related modifier (SUMO) fusion technology in Bacillus subtilis. Secretory SUMO-lacticin Q fusion protein was efficiently produced in B. subtilis WB600 transformed with the recombinant expression plasmid and accounted for 19% of the culture supernatant proteins. Fusion SUMO-lacticin Q was purified by nickel nitrilotriacetate (Ni-NTA) affinity chromatography and digested with SUMO protease to release lacticin Q. Lacticin Q was further purified by Ni-NTA chromatography to yield about 2.5 mg of lacticin Q with more than 93% purity from 1L of supernatant of fermentation culture. An activity assay indicated that the recombinant bacteriocin exhibited excellent antimicrobial activity against indicator strains. The results obtained suggest that the secretory lacticin Q was efficiently expressed using SUMO fusion technology in B. subtilis. The expression and purification system could promote the application of lacticin Q in food and medicine.
Online Inquiry
Verification code
Inquiry Basket